# Progyny, Inc. Announces First Quarter 2026 Results
Canonical URL: https://biopharmsignal.com/news/PGNY/progyny-inc-announces-first-quarter-2026-results
Ticker: PGNY
Company: Progyny
Source: Progyny
Published: 2026-05-07 20:01 EST
Original Source URL: https://investors.progyny.com
## Summary

Reports Record First Quarter Revenue of $328.5 Million Early Selling Season Activity Reflects Robust Demand for Women's Health and Family Building Solutions Returned Value to Shareholders Through Repurchase of 8.8 Million Shares to Date Since November NEW YORK, May 07, 2026 (GLOBE NEWSWIRE) --

## Article Body
Reports Record First Quarter Revenue of $328.5 Million Early Selling Season Activity Reflects Robust Demand for Women's Health and Family Building Solutions Returned Value to Shareholders Through Repurchase of 8.8 Million Shares to Date Since November NEW YORK, May 07, 2026 (GLOBE NEWSWIRE) --
## Recent Company News
- 2026-05-28 13:04 EST — [New Progyny Study Shows Growing Demand for Human Guidance in an Increasingly Digital Healthcare System](https://biopharmsignal.com/news/PGNY/new-progyny-study-shows-growing-demand-for-human-guidance-in-an-increasingly-digital-healthcare-system) — Source: Progyny
- 2026-05-26 12:00 EST — [Progyny, Inc. Announces Share Repurchase Program](https://biopharmsignal.com/news/PGNY/progyny-inc-announces-share-repurchase-program) — Source: Progyny
- 2026-05-11 14:57 EST — [Progyny, Inc. to Present at BofA Securities 2026 Health Care Conference](https://biopharmsignal.com/news/PGNY/progyny-inc-to-present-at-bofa-securities-2026-health-care-conference) — Source: Progyny
- 2026-05-07 20:01 EST — [Progyny, Inc. Announces First Quarter 2026 Results](https://biopharmsignal.com/news/PGNY/progyny-inc-announces-first-quarter-2026-results) — Source: Progyny
- 2026-04-23 17:56 EST — [Progyny, Inc. Announces Details for Its First Quarter 2026 Results Report](https://biopharmsignal.com/news/PGNY/progyny-inc-announces-details-for-its-first-quarter-2026-results-report) — Source: Progyny
## Related News
- 2026-07-21 20:15 EST — BFRG — [BullFrog AI to Participate in Water Tower Research Fireside Chat on Thursday, July 23, 2026](https://biopharmsignal.com/news/BFRG/bullfrog-ai-to-participate-in-water-tower-research-fireside-chat-on-thursday-jul-78357ce8)
- 2026-07-21 20:05 EST — CLPT — [ClearPoint Neuro to Announce Second Quarter 2026 Results August 3, 2026](https://biopharmsignal.com/news/CLPT/clearpoint-neuro-to-announce-second-quarter-2026-results-august-3-2026-6e4f3c05)
- 2026-07-21 20:05 EST — TCMD — [Tactile Medical to Release Second Quarter of Fiscal Year 2026 Financial Results on August 10, 2026](https://biopharmsignal.com/news/TCMD/tactile-medical-to-release-second-quarter-of-fiscal-year-2026-financial-results--798d4004)
- 2026-07-21 20:05 EST — PIII — [P3 Health Partners Schedules Second Quarter 2026 Earnings Release and Conference Call](https://biopharmsignal.com/news/PIII/p3-health-partners-schedules-second-quarter-2026-earnings-release-and-conference-6c9bd8a7)
- 2026-07-21 12:05 EST — VRCA — [Verrica Pharmaceuticals and Medomie Pharma Enter into Exclusive Distribution, Marketing and Supply Agreement to Commercialize YCANTH® for the Treatment of Molluscum Contagiosum in Israel](https://biopharmsignal.com/news/VRCA/verrica-pharmaceuticals-and-medomie-pharma-enter-into-exclusive-distribution-mar-abf61522)